Despite the limitations, the observed efficacy of COVID-HIGIV treatment, when administered 6 h before infection in hamsters or 6 h after infection in mice transduced with adenovirus carrying human ACE2, represent an early treatment scenario. This evidence concerns the gene ACE2 and infection.